All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Glenmark Pharmaceuticals Limited revenue reports

Glenmark Pharmaceuticals Limited financial reports, Glenmark Pharmaceuticals Limited annual revenue in 2024. When does Glenmark Pharmaceuticals Limited report revenue?
Add to widgets
Added to widgets

Glenmark Pharmaceuticals Limited total revenue, net income and dynamics of changes in Indian rupee today

Glenmark Pharmaceuticals Limited revenue for the past few reporting periods. Net revenue of Glenmark Pharmaceuticals Limited on 30/06/2020 amounted to 23 447 870 000 Rs. These are the main financial indicators of Glenmark Pharmaceuticals Limited. Glenmark Pharmaceuticals Limited net income is shown in blue on the graph. All information on Glenmark Pharmaceuticals Limited total revenue on this chart is created in the form of yellow bars. A graph of the value of all Glenmark Pharmaceuticals Limited assets is presented in green bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2020 23 447 870 000 Rs +0.94 % ↑ 2 540 420 000 Rs +132.47 % ↑
31/03/2020 27 674 890 000 Rs +7.96 % ↑ 2 203 080 000 Rs +16.18 % ↑
31/12/2019 27 355 610 000 Rs - 1 908 390 000 Rs -
30/09/2019 28 150 400 000 Rs - 2 555 420 000 Rs -
30/06/2019 23 228 790 000 Rs - 1 092 810 000 Rs -
31/03/2019 25 634 740 000 Rs - 1 896 200 000 Rs -
Show:
to

Glenmark Pharmaceuticals Limited financial report charts

The dates of the latest financial statements of Glenmark Pharmaceuticals Limited: 31/03/2019, 31/03/2020, 30/06/2020. The dates of financial statements are strictly regulated by law and financial statements. The latest date of the financial report of Glenmark Pharmaceuticals Limited is 30/06/2020. Gross profit Glenmark Pharmaceuticals Limited is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Glenmark Pharmaceuticals Limited is 15 364 210 000 Rs

Glenmark Pharmaceuticals Limited quarterly report dates

Cost of revenue Glenmark Pharmaceuticals Limited is the total cost of producing and distributing of products and services of a company. Cost of revenue Glenmark Pharmaceuticals Limited is 8 083 660 000 Rs Total revenue Glenmark Pharmaceuticals Limited refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Glenmark Pharmaceuticals Limited is 23 447 870 000 Rs Operating income Glenmark Pharmaceuticals Limited is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Glenmark Pharmaceuticals Limited is 3 648 460 000 Rs

Net income Glenmark Pharmaceuticals Limited is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Glenmark Pharmaceuticals Limited is 2 540 420 000 Rs

30/06/2020 31/03/2020 31/12/2019 30/09/2019 30/06/2019 31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
15 364 210 000 Rs 16 413 510 000 Rs 18 092 230 000 Rs 18 288 910 000 Rs 15 127 770 000 Rs 15 620 610 000 Rs
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
8 083 660 000 Rs 11 261 380 000 Rs 9 263 380 000 Rs 9 861 490 000 Rs 8 101 020 000 Rs 10 014 130 000 Rs
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
23 447 870 000 Rs 27 674 890 000 Rs 27 355 610 000 Rs 28 150 400 000 Rs 23 228 790 000 Rs 25 634 740 000 Rs
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - 27 355 610 000 Rs 28 150 400 000 Rs 23 228 790 000 Rs 25 634 740 000 Rs
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
3 648 460 000 Rs 3 405 850 000 Rs 3 340 760 000 Rs 3 562 470 000 Rs 2 511 810 000 Rs 3 196 290 000 Rs
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
2 540 420 000 Rs 2 203 080 000 Rs 1 908 390 000 Rs 2 555 420 000 Rs 1 092 810 000 Rs 1 896 200 000 Rs
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
- - - - - -
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
19 799 410 000 Rs 24 269 040 000 Rs 24 014 850 000 Rs 24 587 930 000 Rs 20 716 980 000 Rs 22 438 450 000 Rs
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
- 68 036 160 000 Rs - 65 874 110 000 Rs - 66 968 250 000 Rs
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
- 146 848 070 000 Rs - 138 354 520 000 Rs - 132 887 910 000 Rs
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
- 11 102 750 000 Rs - 9 256 440 000 Rs - 9 362 780 000 Rs
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - 45 309 560 000 Rs - 40 210 940 000 Rs
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - 79 399 300 000 Rs - 76 839 840 000 Rs
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - 57.39 % - 57.82 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
60 705 050 000 Rs 60 705 050 000 Rs 58 958 450 000 Rs 58 958 450 000 Rs 59 952 310 000 Rs 56 051 840 000 Rs
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - - -

Last revenue report of Glenmark Pharmaceuticals Limited was 30/06/2020. According to last financial report total revenue in Glenmark Pharmaceuticals Limited was 23 447 870 000 Indian rupee and changed by +0.94% since last year. Net income in Glenmark Pharmaceuticals Limited was 2 540 420 000 Rs in last quartal, net income changes to +132.47%.

Glenmark Pharmaceuticals Limited stocks data

Glenmark Pharmaceuticals Limited financials